SWDCF Stock Chart & Stats
$2.62
--
Market closed
$2.62
--
Day’s Range― - ―
52-Week Range$2.44 - $5.48
Previous CloseN/A
VolumeN/A
Average Volume (3M)659.00
Market Cap
$363.70M
Enterprise Value$5.69K
Total Cash (Recent Filing)$85.40M
Total Debt (Recent Filing)$1.77B
Price to Earnings (P/E)43.7
Beta0.25
Next Earnings
Oct 21, 2026EPS Estimate
0.04Next Dividend Ex-DateN/A
Dividend Yield0.97%
Share Statistics
EPS (TTM)0.50
Shares Outstanding159,840,960
10 Day Avg. Volume517
30 Day Avg. Volume659
Financial Highlights & Ratios
PEG Ratio-2.52
Price to Book (P/B)0.92
Price to Sales (P/S)2.27
P/FCF Ratio22.24
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$4.63Price Target Upside76.61% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.12
Revenue Forecast (FY)$298.46M
Bulls Say, Bears Say
Bulls Say
Revenue Scaling / Top-line GrowthSustained, multi-year revenue expansion indicates the business is winning distribution and customer adoption across veterinary, retail and e-commerce channels. Durable top-line growth supports economies of scale, funds reinvestment in brands and reduces single-market dependency over a 2–6 month horizon and beyond.
Consistent Free Cash FlowConsistent positive free cash flow gives the company reliable internal funding for marketing, product development and selective M&A without heavy reliance on external financing. Over months this strengthens liquidity and supports strategic initiatives even if margins fluctuate.
Manageable Leverage And Balance-Sheet FlexibilityLow-to-moderate leverage and a growing equity base provide capital flexibility to absorb shocks or pursue growth opportunities. This balance-sheet strength reduces refinancing risk and preserves capacity for investment or integration costs over the medium term.
Bears Say
Sharp Gross-Margin CompressionA sustained drop in gross margin materially reduces the operating leverage that previously amplified revenue growth into profits. If due to structural mix, pricing pressure, or higher COGS, the decline can persist and constrain margin recovery and profitability over coming quarters.
Very Low Net Margin And ROEExtremely low net margins and ROE mean the business currently converts little of sales into shareholder returns. That limits internally generated capital for expansion and makes the company more sensitive to cost shocks, reducing durable returns to equity holders absent margin improvement.
Weakened Cash Conversion / OCF PressureDeclining operating cash flow relative to profitability suggests working-capital strain or cash-timing issues. Weaker cash conversion raises the risk that free cash flow may fluctuate, limiting reliable reinvestment capacity and making the firm more vulnerable to short-term liquidity needs.
SWDCF FAQ
What was Swedencare AB’s price range in the past 12 months?
Swedencare AB lowest stock price was $2.44 and its highest was $5.48 in the past 12 months.
What is Swedencare AB’s market cap?
Swedencare AB’s market cap is $363.70M.
When is Swedencare AB’s upcoming earnings report date?
Swedencare AB’s upcoming earnings report date is Oct 21, 2026 which is in 83 days.
How were Swedencare AB’s earnings last quarter?
Swedencare AB released its earnings results on Jul 22, 2026. The company reported $0.015 earnings per share for the quarter, missing the consensus estimate of $0.026 by -$0.011.
Is Swedencare AB overvalued?
According to Wall Street analysts Swedencare AB’s price is currently Undervalued.
Does Swedencare AB pay dividends?
Swedencare AB pays a Annually dividend of $0.03 which represents an annual dividend yield of 0.97%. See more information on Swedencare AB dividends here
What is Swedencare AB’s EPS estimate?
Swedencare AB’s EPS estimate is 0.04.
How many shares outstanding does Swedencare AB have?
Swedencare AB has 159,840,960 shares outstanding.
What happened to Swedencare AB’s price movement after its last earnings report?
Swedencare AB reported an EPS of $0.015 in its last earnings report, missing expectations of $0.026. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Swedencare AB?
Currently, no hedge funds are holding shares in SWDCF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Swedencare AB
Swedencare AB (publ), an enterprise established in 1993 and headquartered in Malmö, Sweden, operates with its subsidiaries to develop, produce, market, and sell a wide array of healthcare products, predominantly for animals. The company's flagship offering is the ProDen PlaqueOff line, focused on dental hygiene for dogs and cats. This popular range includes a food supplement powder designed to reduce plaque and tartar buildup, along with various chewable formats such as dental bites, bones (including mini versions for smaller dogs), and soft chews suitable for both felines and canines. Beyond dental care, Swedencare provides an extensive selection of nutritional supplements under the NutriScience brand for cats, dogs, and horses. These products address diverse health requirements: Glucosamine and Stomax aid in the rejuvenation of joint cartilage, bones, muscles, ligaments, and sinews; ArthriAid supports joint function and mobility; KalmAid offers a calming effect for anxious dogs; while OmegaAid and RevitalAid are formulated to promote healthy skin and coats. Furthermore, the company manufactures specialized supplements for horses, including Gastrocare to alleviate gastric pain and enhance appetite; Equine Gold for overall vitality; a horse-specific ArthriAid to assist with cartilage formation; and AnxiKalm, aimed at soothing excitable horses. Interestingly, Swedencare also caters to human health with ProDen PlaqueOff Teeth and Gums, a natural dietary supplement designed to boost oral hygiene and prevent tartar accumulation. The company's products are distributed through a broad network that includes pharmacies, veterinary clinics, pet stores, animal hospitals, and online channels.
SWDCF Stock 12 Month Forecast
Average Price Target
$4.63
▲(76.61% Upside)
Ownership Overview
―
Insiders
2.41% Mutual Funds
― Other Institutional Investors
97.42% Public Companies and
Individual Investors






